Literature DB >> 12729627

Structure-activity relationship on human serum paraoxonase (PON1) using substrate analogues and inhibitors.

Rakesh S Bargota1, Mahmoud Akhtar, Keith Biggadike, David Gani, Rudolf K Allemann.   

Abstract

Substrate analogues based on the parent compounds paraoxon and phenyl acetate were tested on human serum paraoxonase (PON1) to explore the active site of the enzyme. Replacement of the nitro group of paraoxon with an amine or hydrogen, as well as electronic changes to the parent compound, converted these analogues into inhibitors. Introduction of either electron-withdrawing or donating groups onto phenyl acetate resulted in reduction in their rate of hydrolysis by PON1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12729627     DOI: 10.1016/s0960-894x(03)00290-7

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Differential effect of lysophospholipids on activities of human plasma paraoxonase1, either soluble or lipid-bound.

Authors:  Cheon Ho Park; Su Duy Nguyen; Mee Ree Kim; Tae-Sook Jeong; Dai-Eun Sok
Journal:  Lipids       Date:  2006-04       Impact factor: 1.880

2.  Naringenin is an inhibitor of human serum paraoxonase (PON1): an in vitro study.

Authors:  Abdolkarim Mahrooz; Mohammad-Reza Rashidi; Mohammad Nouri
Journal:  J Clin Lab Anal       Date:  2011-11       Impact factor: 2.352

3.  Mechanistic Insights into the Hydrolysis of Organophosphorus Compounds by Paraoxonase-1: Exploring the Limits of Substrate Tolerance in a Promiscuous Enzyme.

Authors:  Sivaramakrishnan Muthukrishnan; Vivekanand S Shete; Toby T Sanan; Shubham Vyas; Shameema Oottikkal; Lauren M Porter; Thomas J Magliery; Christopher M Hadad
Journal:  J Phys Org Chem       Date:  2012-12       Impact factor: 2.391

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.